Sort
82,697 grants matching “vaccine development”
Application Of Mass Spectrometry To Structural Biology
$740,180Kenneth Tomer · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES
Multiplex Serodiagnostic Protein Microarray
$740,101Philip Louis Felgner · University Of California-Irvine · U01 · FY2011 · AI
PET Probes Targeting Immune Cells for Imaging Tuberculosis
$740,094Carolyn J Anderson · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · AI
Administrative Core
$740,051David B. Weiner · Wistar Institute · U19 · FY2024 · AI
The Impact of Pre-exisiting SIV on Host Immunity to M tuberculosis in Macaques
$740,051Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AI
Preclinical Development of a Crimean-Congo Hemorrhagic Fever Virus Vaccine
$740,027Thomas William Geisbert · University Of Texas Med Br Galveston · R01 · FY2022 · AI
Preclinical Development of a Crimean-Congo Hemorrhagic Fever Virus Vaccine
$740,024Thomas William Geisbert · University Of Texas Med Br Galveston · R01 · FY2024 · AI
Spatial Multi-omic Analysis of HIV-infected Cell Reservoirs in the Tumor Microenvironment
$740,000Eli Boritz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Delivery of Biological Therapeutics: Using Engineered Particles and Novel Deliver
$740,000Joseph M Desimone · Univ Of North Carolina Chapel Hill · DP1 · FY2009 · OD
Delivery of Biological Therapeutics: Using Engineered Particles and Novel Deliver
$740,000Joseph M Desimone · Univ Of North Carolina Chapel Hill · DP1 · FY2010 · OD
SCC-IRG JST: PanCommunity: Leveraging Data and Models for Understanding and Improving Community Response in Pandemics
$739,996Kasim S Candan · Arizona State University · · FY2021 · CSE
Effective CMV-based SIV vaccine regimens for newborn infants via IL-10 modulation
$739,979Dennis J Hartigan-O'Connor · University Of California At Davis · R01 · FY2023 · AI
Engineered, multispecific antibodies as broad anti-filovirus therapeutics
$739,975Jonathan R. Lai · Albert Einstein College Of Medicine · R01 · FY2020 · AI
In vivo modeling of IgH-reprogrammed B cells in non-human primates
$739,945Chester J. Joyner · Scripps Research Institute, The · P01 · FY2025 · HL
HIV Neutralizing Antibodies: Isolation, characterization, and interaction with viral variants
$739,943Nicole Doria-Rose · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Preclinical Development of a Crimean-Congo Hemorrhagic Fever Virus Vaccine
$739,915Thomas William Geisbert · University Of Texas Med Br Galveston · R01 · FY2023 · AI
Immunostimulatory DNA Priming of Lung Innate Immunity
$739,815Dynavax Technologies Corporation · U01 · FY2003 · AI
Structural and functional definition of human astrovirus-receptor interactions
$739,788Megan T Baldridge · Washington University · R01 · FY2024 · AI
Johns Hopkins University-Guangxi, China Clinical Trials Unit
$739,713Jay B Jackson · Johns Hopkins University · UM1 · FY2012 · AI
Mechanisms of Chronic Hepatitis B Infection and Therapeutic Vaccines
$739,678David R. Milich · Vaccine Research Institute Of San Diego · R01 · FY2007 · AI
Role of the microbiome in HIV vaccine induced heterogeneity
$739,661James G. Kublin · Fred Hutchinson Cancer Research Center · R01 · FY2019 · AI
Glycosylation Mutants of Leishmania
$739,661Stephen M Beverley · Washington University · R01 · FY2008 · AI
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2
$739,638Susan C. Baker · Loyola University Chicago · R01 · FY2024 · AI
Development of botulinum neurotoxin immunotherapy, serotypes C, D, F, and G
$739,630James D. Marks · University Of California, San Francisco · U01 · FY2011 · AI
Broad spectrum inhibitors of paramyxovirus envelope proteins
$739,596Anne Moscona · Columbia University Health Sciences · R01 · FY2025 · AI